Swietenialide D - Compound Card

Swietenialide D

Select a section from the left sidebar

Swietenialide D

Structure
Zoomed Structure
  • Family: Plantae - Meliaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Limonoid
Canonical Smiles CCC(=O)O[C@@H]1[C@@H](O)[C@@H](OC(=O)C2(C)OC2C)[C@]2(C)CC3[C@]([C@@]45[C@]1(OC(O4)(C)O3)[C@H](CC(=O)OC)[C@@](C)(C[C@H]5O)[C@H](c1ccoc1)OC(=O)C)([C@H]2CC(=O)OC)C
InChI InChI=1S/C40H54O17/c1-11-26(43)52-32-29(46)31(53-33(47)37(7)19(2)54-37)35(5)17-25-36(6,22(35)14-27(44)48-9)40-24(42)16-34(4,30(51-20(3)41)21-12-13-50-18-21)23(15-28(45)49-10)39(32,40)56-38(8,55-25)57-40/h12-13,18-19,22-25,29-32,42,46H,11,14-17H2,1-10H3/t19?,22-,23+,24+,25?,29-,30-,31+,32+,34+,35+,36+,37?,38?,39-,40-/m0/s1
InChIKey SBOCNDPVWBAYNN-YOPGOPOFSA-N
Formula C40H54O17
HBA 17
HBD 2
MW 806.86
Rotatable Bonds 11
TPSA 225.32
LogP 2.81
Number Rings 7
Number Aromatic Rings 1
Heavy Atom Count 57
Formal Charge 0
Fraction CSP3 0.78
Exact Mass 806.34
Number of Lipinski Rule Violations 2
# Species Family Kingdom NCBI Taxonomy ID
1 Swietenia mahogani Meliaceae Plantae 459165

Showing of synonyms

  • Saad MMG, Iwagawa T, et al. (2003). Swietenialides, novel ring D opened phragmalin limonoid orthoesters from Swietenia mahogani JACQ.. Tetrahedron,2003,59(40),8027-8033. [View]
Pubchem: 101758882
Nmrshiftdb2: 70061359

No compound-protein relationship available.

Structure

SMILES: O1C(O2)OC(C3)C4CC3C(OC(=O)C5CO5)CCC2(C146)CC(CC6)Cc7ccoc7

Level: 2

Mol. Weight: 806.86 g/mol

Structure

SMILES: O1C(O2)OC(C3)C4CC3C(OC(=O)C5CO5)CCC2(C146)CCCC6

Level: 1

Mol. Weight: 806.86 g/mol

Structure

SMILES: c1occc1CC(CC2)CC3(C245)CCCC6CC4C(C6)OC(O5)O3

Level: 1

Mol. Weight: 806.86 g/mol

Structure

SMILES: C1CCCC2(C134)CCCC5CC3C(C5)OC(O4)O2

Level: 0

Mol. Weight: 806.86 g/mol

Structure

SMILES: c1ccoc1

Level: 0

Mol. Weight: 806.86 g/mol

Structure

SMILES: C1CO1

Level: 0

Mol. Weight: 806.86 g/mol

Antifeedant

Absorption

Caco-2 (logPapp)
-5.34
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
27.97
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
4348.94

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.07
Plasma Protein Binding
70.27
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
8.98
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-106.2
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.48
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
6.23
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-7896730.46
Rat (Acute)
5.46
Rat (Chronic Oral)
3.48
Fathead Minnow
9972.97
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
883962.92
Hydration Free Energy
-2.92
Log(D) at pH=7.4
2.4
Log(P)
3.4
Log S
-4.84
Log(Vapor Pressure)
-29040.17
Melting Point
175.22
pKa Acid
-173.15
pKa Basic
-2.9

No predicted protein targets found for this compound.

Download SDF